Norlase has been granted CE mark for the Leaf laser for treatment of glaucoma and retinal diseases, according to a press release.
The Leaf is a first-in-class compact green photocoagulator that attaches to an existing slit lamp, with a wireless tablet user interface and an optional voice control feature that allows for no-touch control during treatment, the release said.
The Leaf was granted 510(k) marketing approval by the FDA in October 2019.
“CE mark approval allows Norlase to market and distribute Leaf in the European Union and many other countries (Read more...)
Uncategorized